Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples